StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
82
This month
2
This year
10
Publishing Date
2024 - 03 - 12
2
2023 - 10 - 31
2
2023 - 09 - 26
1
2023 - 09 - 25
1
2023 - 09 - 15
1
2023 - 09 - 11
1
2023 - 08 - 30
1
2023 - 08 - 28
1
2023 - 08 - 09
2
2023 - 07 - 25
1
2023 - 06 - 23
1
2023 - 05 - 24
1
2023 - 05 - 10
2
2023 - 05 - 09
1
2023 - 04 - 30
1
2023 - 04 - 12
1
2023 - 03 - 27
1
2023 - 03 - 13
1
2023 - 03 - 09
1
2023 - 03 - 08
1
2023 - 03 - 01
2
2023 - 02 - 07
1
2023 - 02 - 02
1
2023 - 01 - 27
1
2023 - 01 - 25
2
2023 - 01 - 22
1
2022 - 12 - 15
1
2022 - 11 - 15
1
2022 - 09 - 15
1
2022 - 09 - 01
1
2022 - 08 - 02
1
2022 - 07 - 21
1
2022 - 07 - 12
1
2022 - 07 - 10
1
2022 - 06 - 24
1
2022 - 06 - 22
1
2022 - 06 - 16
1
2022 - 05 - 18
1
2022 - 05 - 03
1
2022 - 05 - 02
1
2022 - 04 - 05
1
2022 - 03 - 17
1
2022 - 03 - 01
1
2022 - 02 - 28
1
2022 - 02 - 24
2
2022 - 01 - 11
1
2021 - 12 - 21
1
2021 - 11 - 18
1
2021 - 11 - 09
1
2021 - 10 - 07
1
2021 - 09 - 07
1
2021 - 09 - 03
1
2021 - 08 - 03
1
2021 - 05 - 10
1
2021 - 05 - 05
1
2021 - 04 - 05
1
2021 - 03 - 16
2
2021 - 02 - 18
1
2021 - 01 - 12
1
2021 - 01 - 04
1
Sector
Consumer services
1
Health technology
82
Manufacturing
3
Tags
Alliances
1
Annual needham
1
Annual needham virtual healthcare conference
1
Association
1
Bay
1
Bexotegrast
8
Biotech
1
Biotech-bay
7
Biotechnology
2
Cancer
2
Clearance
1
Clinical-trials-phase-ii
2
Collaboration
1
Conference
15
Congress
1
Designation
3
Drug
1
Enroll
1
Events
4
Fast track designation
2
Fda
3
Fda-approvals
2
Fibrosis
14
Financial
5
Financial results
4
Growth
1
Health
2
Imaging
1
Immunotherapy
2
International
8
Iot
1
J.p. morgan healthcare conference
1
Liver
5
Market
2
Meeting
4
Milestone
1
N/a
60
Needham virtual healthcare conference
1
Offering
3
Ongoing
1
People
3
Phase 1
2
Phase 1b
1
Phase 2
4
Phase 2b
8
Pln-1010
2
Pln-7480
10
Positive
10
Pre-clinical
2
Preclinical
2
Program
2
Respiratory
2
Results
10
Review
2
Sclerosing cholangitis
2
Study
2
Therapeutics
70
Treatment
6
Trial
14
Update
5
Entities
Arrival
2
Astellas pharma inc
1
Calliditas therapeutics ab
1
Cymabay therapeutics inc.
1
Eli lilly and company
1
Johnson & johnson
1
Marker therapeutics, inc.
1
Nektar therapeutics
1
Novartis ag
1
Pliant therapeutics, inc.
82
Sanofi
2
Symbols
AAPL
1197
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7189
FRBA
598
GE
916
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4284
MSFT
1201
MT
589
NOC
589
NOK
900
NOKBF
974
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1622
VZ
1213
XYF
676
Exchanges
Nasdaq
82
Nyse
3
Crawled Date
2024 - 03 - 12
2
2023 - 10 - 31
2
2023 - 09 - 26
1
2023 - 09 - 25
1
2023 - 09 - 15
1
2023 - 09 - 11
1
2023 - 08 - 30
1
2023 - 08 - 28
1
2023 - 08 - 09
2
2023 - 07 - 25
1
2023 - 06 - 23
1
2023 - 05 - 24
1
2023 - 05 - 10
2
2023 - 05 - 09
1
2023 - 04 - 30
1
2023 - 04 - 12
1
2023 - 03 - 27
1
2023 - 03 - 13
1
2023 - 03 - 10
1
2023 - 03 - 09
1
2023 - 03 - 01
2
2023 - 02 - 07
1
2023 - 02 - 02
1
2023 - 01 - 27
1
2023 - 01 - 25
2
2023 - 01 - 22
1
2022 - 12 - 15
1
2022 - 11 - 15
1
2022 - 09 - 15
1
2022 - 09 - 01
1
2022 - 08 - 02
1
2022 - 07 - 21
1
2022 - 07 - 13
1
2022 - 07 - 11
1
2022 - 06 - 24
1
2022 - 06 - 22
1
2022 - 06 - 16
1
2022 - 05 - 18
1
2022 - 05 - 03
1
2022 - 05 - 02
1
2022 - 04 - 05
1
2022 - 03 - 17
1
2022 - 03 - 01
1
2022 - 02 - 28
1
2022 - 02 - 24
2
2022 - 01 - 11
1
2021 - 12 - 21
1
2021 - 11 - 18
1
2021 - 11 - 09
1
2021 - 10 - 07
1
2021 - 09 - 07
1
2021 - 09 - 03
1
2021 - 08 - 03
1
2021 - 05 - 10
1
2021 - 05 - 05
1
2021 - 04 - 05
1
2021 - 03 - 16
2
2021 - 02 - 18
1
2021 - 01 - 12
1
2021 - 01 - 04
1
Crawled Time
00:00
4
01:00
2
03:00
1
12:00
12
12:15
3
12:20
6
13:00
8
13:03
2
13:20
4
13:30
2
14:00
6
14:15
1
14:20
2
14:30
1
15:00
2
15:20
1
15:30
1
16:00
1
17:00
1
18:00
1
20:00
6
20:20
2
21:00
7
22:00
5
23:00
1
Source
www.biospace.com
22
www.globenewswire.com
58
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
PLRX
save search
Pliant Therapeutics to Participate in Upcoming Investor Events
Published:
2023-02-07
(Crawled : 14:00)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-62.62%
|
O:
0.34%
H:
0.0%
C:
-1.34%
therapeutics
Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for PLN-101095, A Novel Integrin Inhibitor for the Treatment of Solid Tumors
Published:
2023-02-02
(Crawled : 13:20)
- globenewswire.com
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-64.62%
|
O:
0.64%
H:
2.42%
C:
-1.93%
pln-1010
treatment
fda
clearance
drug
therapeutics
tumors
Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published:
2023-01-27
(Crawled : 22:00)
- globenewswire.com
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
Email alert
Add to watchlist
offering
therapeutics
Pliant Therapeutics Announces Appointment of Lily Cheung as Chief Human Resources Officer
Published:
2023-01-25
(Crawled : 13:00)
- globenewswire.com
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-13.88%
|
O:
-0.68%
H:
1.4%
C:
1.4%
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-62.99%
|
O:
-0.33%
H:
5.82%
C:
5.54%
therapeutics
Pliant Therapeutics Announces Pricing of Upsized $250.0 Million Public Offering
Published:
2023-01-25
(Crawled : 03:00)
- globenewswire.com
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-62.99%
|
O:
-0.33%
H:
5.82%
C:
5.54%
offering
therapeutics
Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis
Published:
2023-01-22
(Crawled : 20:20)
- globenewswire.com
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-45.85%
|
O:
55.66%
H:
4.17%
C:
-13.58%
fibrosis
trial
therapeutics
positive
phase 2b
Pliant Therapeutics Receives Orphan Designation from the European Medicines Agency for Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis
Published:
2022-12-15
(Crawled : 21:00)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-36.44%
|
O:
-1.72%
H:
3.29%
C:
3.02%
pln-7480
treatment
fibrosis
designation
therapeutics
Pliant Therapeutics to Participate in Upcoming Investor Conferences
Published:
2022-11-15
(Crawled : 13:00)
- globenewswire.com
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-40.48%
|
O:
2.64%
H:
5.71%
C:
3.14%
therapeutics
Pliant Therapeutics Announces Appointment of Katharine Knobil, M.D. to Board of Directors
Published:
2022-09-15
(Crawled : 14:00)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-49.69%
|
O:
-1.4%
H:
0.96%
C:
-0.04%
therapeutics
Pliant Therapeutics Announces Positive DSMB Safety Review of INTEGRIS-IPF Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis
Published:
2022-09-01
(Crawled : 14:20)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-36.77%
|
O:
1.76%
H:
4.84%
C:
3.47%
pln-7480
fibrosis
trial
therapeutics
review
positive
phase 2b
Pliant Therapeutics to Participate in BTIG Biotechnology Conference
Published:
2022-08-02
(Crawled : 14:20)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-26.12%
|
O:
-1.15%
H:
6.87%
C:
6.01%
conference
therapeutics
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Primary Sclerosing Cholangitis
Published:
2022-07-21
(Crawled : 14:00)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-38.09%
|
O:
0.41%
H:
0.7%
C:
-1.62%
pln-7480
treatment
fda
designation
therapeutics
fast track designation
sclerosing cholangitis
Pliant Therapeutics Announces Pricing of Upsized $200.0 Million Public Offering
Published:
2022-07-12
(Crawled : 00:00)
- globenewswire.com
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
-38.96%
|
O:
-0.25%
H:
2.86%
C:
-6.07%
offering
therapeutics
Pliant Therapeutics Announces Positive Safety and Efficacy Data from Phase 2a INTEGRIS-IPF Clinical Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis
Published:
2022-07-10
(Crawled : 00:00)
- globenewswire.com
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
37.27%
|
O:
80.29%
H:
43.66%
C:
43.66%
pln-7480
fibrosis
trial
therapeutics
positive
phase 2b
Pliant Therapeutics Announces Presentations at the International Liver Congress™ 2022 Highlighting Preclinical and Clinical Data in Support of the INTEGRIS-PSC Phase 2a Clinical Trial
Published:
2022-06-24
(Crawled : 12:20)
- globenewswire.com
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
46.87%
|
O:
0.96%
H:
12.77%
C:
-2.39%
preclinical
trial
therapeutics
pre-clinical
phase 2b
Pliant Therapeutics Presents Preclinical Data Highlighting A Novel Approach for the Treatment of Muscular Dystrophies
Published:
2022-06-22
(Crawled : 13:20)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
61.89%
|
O:
-1.46%
H:
9.43%
C:
5.39%
treatment
preclinical
therapeutics
pre-clinical
Pliant Therapeutics Announces Advancement of Integrin Target in Fibrosis Under Strategic Collaboration
Published:
2022-06-16
(Crawled : 13:00)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
75.14%
|
O:
-4.74%
H:
3.7%
C:
2.56%
fibrosis
collaboration
therapeutics
Pliant Therapeutics Announces Presentations at 2022 American Thoracic Society International Conference
Published:
2022-05-18
(Crawled : 15:20)
- globenewswire.com
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
147.76%
|
O:
-3.25%
H:
8.19%
C:
1.68%
conference
therapeutics
international
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Idiopathic Pulmonary Fibrosis
Published:
2022-05-03
(Crawled : 13:20)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
115.75%
|
O:
0.88%
H:
2.62%
C:
-5.26%
pln-7480
treatment
fda
fibrosis
designation
therapeutics
fast track designation
Pliant Therapeutics Announces Multiple Presentations at the 2022 American Thoracic Society International Conference
Published:
2022-05-02
(Crawled : 14:00)
- biospace.com/
PLRX
|
$12.11
-0.66%
120K
|
Health Technology
|
108.02%
|
O:
-0.85%
H:
6.37%
C:
-2.75%
conference
therapeutics
international
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
71%
29%
Top 10 Gainers
AGBA
|
News
|
$1.27
217.5%
120M
|
Finance
EGOX
|
$0.0503
39.72%
320M
|
RWOD
|
$10.52
31.56%
5.9M
|
n/a
ZCMD
|
$1.905
31.38%
30M
|
Commercial Services
MRDB
4
|
$0.536
27.65%
2M
|
n/a
BSFC
|
$0.0822
27.64%
75M
|
Manufacturing
TPET
|
$0.4121
25.68%
45M
|
n/a
NVFY
|
$2.65
25.59%
33M
|
Consumer Durables
INDO
|
$5.1
25.0%
15M
|
Energy Minerals
CHRO
|
$1.53
24.9%
100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.